Legend Biotech (LEGN) Profit After Tax (2019 - 2025)
Legend Biotech (LEGN) posted Profit After Tax of -$30.9 million for Q4 2025, up 22.14% on a QoQ basis from -$39.7 million in Q3 2025, and down 217.05% year-over-year from $26.4 million in Q4 2024.
Legend Biotech (LEGN) Profit After Tax (2019 - 2025) Analysis & Trends
Legend Biotech's Profit After Tax history runs 7 years deep, the most recent figure standing at -$30.9 million for Q4 2025.
- Quarterly Profit After Tax fell 217.05% year-over-year to -$30.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$135.2 million (up 18.09% YoY) and the FY2025 annual result came in at $296.8 million, up 67.68% from the prior year.
- Profit After Tax was -$30.9 million for Q4 2025 at Legend Biotech, up from -$39.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $60.7 million in Q1 2025 and bottomed at -$198.5 million in Q2 2023.
- A 5-year average of -$63.3 million and a median of -$55.4 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax sank 6676.61% — and 2024, when it soared 18329.78%.
- Legend Biotech's Profit After Tax stood at -$84.7 million in 2021, then sank by 60.2% to -$135.7 million in 2022, then jumped by 99.89% to -$144818.0 in 2023, then surged by 18329.78% to $26.4 million in 2024, then slumped by 217.05% to -$30.9 million in 2025.
- Business Quant data shows LEGN's Profit After Tax at -$30.9 million in Q4 2025, -$39.7 million in Q3 2025, and -$125.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -30.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.90 Mn |
| Sep 30, 2025 | -39.69 Mn |
| Jun 30, 2025 | -125.38 Mn |
| Mar 31, 2025 | 60.73 Mn |
| Dec 31, 2024 | 26.40 Mn |
| Sep 30, 2024 | -125.32 Mn |
| Jun 30, 2024 | -18.20 Mn |
| Mar 31, 2024 | -47.99 Mn |
| Dec 31, 2023 | -144,818.00 |
| Sep 30, 2023 | -62.78 Mn |
| Jun 30, 2023 | -198.55 Mn |
| Mar 31, 2023 | -111.85 Mn |
| Dec 31, 2022 | -135.72 Mn |
| Sep 30, 2022 | -84.80 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | -84.72 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -172.38 Mn |
| Mar 31, 2021 | 4.35 Mn |